| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-SREK1 (1-180) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
SREK1 |
| Gene ID: |
140890 |
| Uniprot ID: |
SREK1_HUMAN |
| Immunogen Region: |
1-180 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-180 of human SREK1 (NP_631907.1). |
| Immunogen Sequence: |
MTSLMPGAGLLPIPTPNPLT TLGVSLSSLGAIPAAALDPN IATLGEIPQPPLMGNVDPSK IDEIRRTVYVGNLNSQTTTA DQLLEFFKQVGEVKFVRMAG DETQPTRFAFVEFADQNSVP RALAFNGVMFGDRPLKINHS NNAIVKPPEMTPQAAAKELE EVMKRVREAQSFISAAIEPE |
| Function | Participates in the regulation of alternative splicing by modulating the activity of other splice facors. Inhibits the splicing activity of SFRS1, SFRS2 and SFRS6. Augments the splicing activity of SFRS3. |
| Protein Name | Splicing Regulatory Glutamine/Lysine-Rich Protein 1Serine/Arginine-Rich-Splicing Regulatory Protein 86Srrp86Splicing Factor - Arginine/Serine-Rich 12Splicing Regulatory Protein 508Srrp508 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Splicing Regulatory Glutamine/Lysine-Rich Protein 1 antibodyAnti-Serine/Arginine-Rich-Splicing Regulatory Protein 86 antibodyAnti-Srrp86 antibodyAnti-Splicing Factor - Arginine/Serine-Rich 12 antibodyAnti-Splicing Regulatory Protein 508 antibodyAnti-Srrp508 antibodyAnti-SREK1 antibodyAnti-SFRS12 antibodyAnti-SRRP86 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
